Clinical Trials Directory

Trials / Conditions / Chronic HBV Infection

Chronic HBV Infection

21 registered clinical trials studyying Chronic HBV Infection — 5 currently recruiting.

StatusTrialSponsorPhase
Not Yet RecruitingA Long-term Observational Study in Participants Who Have Received PBGENE-HBV
NCT07254208
Precision BioSciences, Inc.—
RecruitingStudy of LW231 in Participants With Chronic Hepatitis B
NCT07179575
Shanghai Longwood Biopharmaceuticals Co., Ltd.Phase 1 / Phase 2
RecruitingMethylene Blue Treatment of Chronic Hepatitis B Virus Infection
NCT06887036
Fondazione Epatocentro TicinoPhase 2
Not Yet RecruitingEffect of Long-Term Use of Tenofovir (TDF) on Bone Density in Patients With Chronic Hepatitis B
NCT06990438
Assiut University—
Not Yet RecruitingEffect of Tenofovir (TDF) on Renal Function in Patients With Chronic Hepatitis B
NCT06896630
Assiut University—
CompletedStudy to Evaluate the Safety, Tolerance, Pharmacokinetics Characteristics of PA3670 Tablets in Chinese Healthy
NCT05851261
Zhejiang Palo Alto Pharmaceuticals, Inc.Phase 1
CompletedA Study to Evaluate the Antiviral Activity and Safety of HH-003 in Chronic Hepatitis B Subjects With Low-level
NCT05734807
Huahui HealthPhase 2
CompletedStudy of the Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Characteristics of PA1010 in HBV Patien
NCT05019040
Zhejiang Palo Alto Pharmaceuticals, Inc.Phase 1 / Phase 2
UnknownA Study on Antiviral Treatment of Chronic Hepatitis B in Children
NCT05792761
Fang WangN/A
CompletedA Study of EDP-514 in Patients With Chronic Hepatitis B Virus Infection Who Are Not Currently on Treatment
NCT04470388
Enanta Pharmaceuticals, IncPhase 1
CompletedEffects of T-bet B Cells in Persistent Virus Control After Discontinuance of NAs in CHB Patients
NCT06029634
Changhai Hospital—
CompletedStudy of the Safety, Tolerability, Pharmacokinetic Characteristics of PA1010 in Healthy Subjects
NCT05468060
Zhejiang Palo Alto Pharmaceuticals, Inc.Phase 1
CompletedA Study to Evaluate the Safety, Tolerability of HH-003 Injection in Participants With Chronic Hepatitis B Viru
NCT05542979
Huahui HealthPhase 1
CompletedA Study of EDP-514 in Healthy Subjects (Part 1) and Patients With Chronic Hepatitis B Virus Infection (Part 2)
NCT04008004
Enanta Pharmaceuticals, IncPhase 1
CompletedEvaluate the Safety, Tolerability, and Antiviral Activity of GLS4 With Ritonavir in Patients With Chronic HBV
NCT04147208
Sunshine Lake Pharma Co., Ltd.Phase 2
Completedto Evaluate the Efficacy and Safety of Eltrombopag for Immune Thrombocytopenia With Chronic HBV Infection
NCT03664518
Institute of Hematology & Blood Diseases Hospital, ChinaPhase 2
CompletedStudy of the Efficacy and Safety of HS-10234 in Patients With Chronic Hepatitis B Virus Infection
NCT03903796
Jiangsu Hansoh Pharmaceutical Co., Ltd.Phase 3
CompletedSerum HBV RNA Value on Chronic Hepatitis B Virus Infection Manage
NCT03909191
Changhai Hospital—
CompletedTenofovir Alafenamide Versus Tenofovir Disoproxil Fumarate for Treatment of Hepatitis B e Antigen-Positive Hep
NCT02836249
Gilead SciencesPhase 3
CompletedTenofovir Alafenamide Versus Tenofovir Disoproxil Fumarate for Treatment of Hepatitis B e Antigen-Negative Hep
NCT02836236
Gilead SciencesPhase 3
CompletedSafety and Efficacy of GS-4774 for the Treatment of Chronic Hepatitis B
NCT01943799
Gilead SciencesPhase 2